Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Jun;58(6):1187-92.
doi: 10.1111/j.1532-5415.2010.02939.x.

Comparative effectiveness research priorities at federal agencies: the view from the Department of Veterans Affairs, National Institute on Aging, and Agency for Healthcare Research and Quality

Timothy J O'Leary  1 , Jean R Slutsky, Marie A Bernard
Affiliations

Comparative effectiveness research priorities at federal agencies: the view from the Department of Veterans Affairs, National Institute on Aging, and Agency for Healthcare Research and Quality

Timothy J O'Leary et al. J Am Geriatr Soc. 2010 Jun.

Abstract

In the last year, attention has been focused on translating federally sponsored health research into better health for Americans. Since the passage of the American Recovery and Reinvestment Act (ARRA) on February 17, 2009, ARRA funds to support Comparative Effectiveness Research (CER) have increased this focus. A large proportion of topical areas of interest in CER affects the older segment of the population. The Department of Veterans Affairs (VA), the National Institute on Aging (NIA), and the Agency for Healthcare Research and Quality (AHRQ) have supported robust research portfolios focused on aging populations that meet the varying definitions of CER. This short article briefly describes the research missions of the AHRQ, NIA, and VA. The various definitions of CER as the Congressional Budget Office, the Institute of Medicine, and the ARRA-established Federal Coordinating Council have put forward, as well as important topics for which CER is particularly needed, are then reviewed. Finally, approaches in which the three agencies support CER involving the aging population are set forth and opportunities for future CER research outlined.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: The editor in chief has reviewed the conflict of interest checklist provided by the authors and has determined that the authors have no financial or any other kind of personal conflicts with this paper.

Figures

Figure 1
Figure 1
Agency for Healthcare Research and Quality Stakeholder Input and Involvement Process
See this image and copyright information in PMC

References

    1. National Institutes of Health. Research Reporting On-line Tools (RePORT) Estimates for Funding for Various Research, Conditions, and Disease Categories (RCDC) [Accessed 3.6.10]. http://report.nih.gov/rcdc/categories/
    1. A CBO Paper: Research on the Comparative Effectiveness of Medical Treatments. Congress of the United States Congressional Budget Office. Pub. No. 2975. Dec2007. [Accessed 1.26.10]. p. 3. http://www.cbo.gov/ftpdocs/88xx/doc8891/12-18-ComparativeEffectiveness.pdf.
    1. US Food and Drug Administration. About FDA: what we do. [Accessed 3.16.10]. http://www.fda.gov/AboutFDA/WhatWeDo/default.htm.
    1. Code of Federal Regulations. Title 21, part 314-Applications for FDA approval to market a new drug: subpart D-FDA action on applications and abbreviated applications. Section 314.125-Refusal to approve an application. [Accessed 3.16.10]. http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr....

    1. Federal Register/Vol. 68, No. 187/Friday, September 26, 2003/Notices. Department of Human Services, Centers for Medicare & Medicaid Services. Medicare Program; Revised Process for Making Medicare National Coverage Determinations

MeSH terms